 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
1nr1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase
|
 |
|
Title:
|
 |
Crystal structure of the r463a mutant of human glutamate dehydrogenase
|
|
Structure:
|
 |
Glutamate dehydrogenase 1. Chain: a, b, c, d, e, f. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
3.30Å
|
R-factor:
|
0.222
|
R-free:
|
0.284
|
|
|
Authors:
|
 |
S.Banerjee,T.Schmidt,J Fang,C.A.Stanley,T.J.Smith
|
Key ref:
|
 |
S.Banerjee
et al.
(2003).
Structural studies on ADP activation of mammalian glutamate dehydrogenase and the evolution of regulation.
Biochemistry,
42,
3446-3456.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
23-Jan-03
|
Release date:
|
06-May-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P00367
(DHE3_HUMAN) -
Glutamate dehydrogenase 1, mitochondrial
|
|
|
|
Seq: Struc:
|
 |
 |
 |
558 a.a.
496 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.4.1.3
- Glutamate dehydrogenase (NAD(P)(+)).
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-glutamate + H2O + NAD(P)(+) = 2-oxoglutarate + NH3 + NAD(P)H
|
 |
 |
 |
 |
 |
L-glutamate
|
+
|
H(2)O
|
+
|
NAD(P)(+)
|
=
|
2-oxoglutarate
|
+
|
NH(3)
|
+
|
NAD(P)H
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
oxidation-reduction process
|
2 terms
|
 |
|
Biochemical function
|
nucleotide binding
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
42:3446-3456
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural studies on ADP activation of mammalian glutamate dehydrogenase and the evolution of regulation.
|
|
S.Banerjee,
T.Schmidt,
J.Fang,
C.A.Stanley,
T.J.Smith.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Glutamate dehydrogenase (GDH) is found in all organisms and catalyzes the
reversible oxidative deamination of L-glutamate to 2-oxoglutarate. Unlike GDH
from bacteria, mammalian GDH exhibits negative cooperativity with respect to
coenzyme, activation by ADP, and inhibition by GTP. Presented here are the
structures of apo bovine GDH, bovine GDH complexed with ADP, and the R463A
mutant form of human GDH (huGDH) that is insensitive to ADP activation. In the
absence of active site ligands, the catalytic cleft is in the open conformation,
and the hexamers form long polymers in the crystal cell with more interactions
than found in the abortive complex crystals. This is consistent with the fact
that ADP promotes aggregation in solution. ADP is shown to bind to the second,
inhibitory, NADH site yet causes activation. The beta-phosphates of the bound
ADP interact with R459 (R463 in huGDH) on the pivot helix. The structure of the
ADP-resistant, R463A mutant of human GDH is identical to native GDH with the
exception of the truncated side chain on the pivot helix. Together, these
results strongly suggest that ADP activates by facilitating the opening of the
catalytic cleft. From alignment of GDH from various sources, it is likely that
the antenna evolved in the protista prior to the formation of purine regulatory
sites. This suggests that there was some selective advantage of the antenna
itself and that animals evolved new functions for GDH through the addition of
allosteric regulation.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Q.Shi,
H.Hong,
J.Senior,
and
W.Tong
(2010).
Biomarkers for drug-induced liver injury.
|
| |
Expert Rev Gastroenterol Hepatol, 4,
225-234.
|
 |
|
|
|
|
 |
K.Kanavouras,
N.Borompokas,
H.Latsoudis,
A.Stagourakis,
I.Zaganas,
and
A.Plaitakis
(2009).
Mutations in human GLUD2 glutamate dehydrogenase affecting basal activity and regulation.
|
| |
J Neurochem, 109,
167-173.
|
 |
|
|
|
|
 |
M.Li,
C.J.Smith,
M.T.Walker,
and
T.J.Smith
(2009).
Novel inhibitors complexed with glutamate dehydrogenase: allosteric regulation by control of protein dynamics.
|
| |
J Biol Chem, 284,
22988-23000.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.B.Carrigan,
and
P.C.Engel
(2008).
The structural basis of proteolytic activation of bovine glutamate dehydrogenase.
|
| |
Protein Sci, 17,
1346-1353.
|
 |
|
|
|
|
 |
L.Li,
E.A.Monckton,
and
R.Godbout
(2008).
A role for DEAD box 1 at DNA double-strand breaks.
|
| |
Mol Cell Biol, 28,
6413-6425.
|
 |
|
|
|
|
 |
S.Bigdeli,
A.H.Talasaz,
P.Ståhl,
H.H.Persson,
M.Ronaghi,
R.W.Davis,
and
M.Nemat-Gorgani
(2008).
Conformational flexibility of a model protein upon immobilization on self-assembled monolayers.
|
| |
Biotechnol Bioeng, 100,
19-27.
|
 |
|
|
|
|
 |
T.J.Smith,
and
C.A.Stanley
(2008).
Untangling the glutamate dehydrogenase allosteric nightmare.
|
| |
Trends Biochem Sci, 33,
557-564.
|
 |
|
|
|
|
 |
K.Kanavouras,
V.Mastorodemos,
N.Borompokas,
C.Spanaki,
and
A.Plaitakis
(2007).
Properties and molecular evolution of human GLUD2 (neural and testicular tissue-specific) glutamate dehydrogenase.
|
| |
J Neurosci Res, 85,
1101-1109.
|
 |
|
|
|
|
 |
K.Kanavouras,
V.Mastorodemos,
N.Borompokas,
C.Spanaki,
and
A.Plaitakis
(2007).
Properties and molecular evolution of human GLUD2 (neural and testicular tissue-specific) glutamate dehydrogenase.
|
| |
J Neurosci Res, 85,
3398-3406.
|
 |
|
|
|
|
 |
M.Hamelin,
J.Mary,
M.Vostry,
B.Friguet,
and
H.Bakala
(2007).
Glycation damage targets glutamate dehydrogenase in the rat liver mitochondrial matrix during aging.
|
| |
FEBS J, 274,
5949-5961.
|
 |
|
|
|
|
 |
M.Li,
A.Allen,
and
T.J.Smith
(2007).
High throughput screening reveals several new classes of glutamate dehydrogenase inhibitors.
|
| |
Biochemistry, 46,
15089-15102.
|
 |
|
|
|
|
 |
M.M.Choi,
E.A.Kim,
S.J.Yang,
S.Y.Choi,
S.W.Cho,
and
J.W.Huh
(2007).
Amino acid changes within antenna helix are responsible for different regulatory preferences of human glutamate dehydrogenase isozymes.
|
| |
J Biol Chem, 282,
19510-19517.
|
 |
|
|
|
|
 |
E.Jaspard
(2006).
A computational analysis of the three isoforms of glutamate dehydrogenase reveals structural features of the isoform EC 1.4.1.4 supporting a key role in ammonium assimilation by plants.
|
| |
Biol Direct, 1,
38.
|
 |
|
|
|
|
 |
V.Mastorodemos,
I.Zaganas,
C.Spanaki,
M.Bessa,
and
A.Plaitakis
(2005).
Molecular basis of human glutamate dehydrogenase regulation under changing energy demands.
|
| |
J Neurosci Res, 79,
65-73.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|